08:48 AM EDT, 04/05/2024 (MT Newswires) -- Sanofi ( SNY ) said Friday it has launched its rabies vaccine Verorab in the UK for pre- and post-exposure prophylaxis needs across all age groups.

The vaccine is launched based on clinical data from more than 13,000 individuals, the company said.

Shares of Sanofi ( SNY ) declined 1.5% in recent premarket activity on Friday.

Price: 47.08, Change: -0.72, Percent Change: -1.51